The global virus filtration market size was USD 3.64 billion in 2022 and is expected to reach USD 10.09 billion in 2032, and register a revenue CAGR of 12% during the forecast period. Another significant factor driving the virus filtration market revenue growth is the adoption of stringent regulatory laws and standards for the production of Biologics and Vaccines. Government rules require the use of virus filtration technology, which hastens the demand for sophisticated and effective virus filtration systems in the biopharmaceutical sector. These restrictions aim to minimize the potential risk of viral contamination in biologic goods.
Another reason driving revenue growth of the virus filtration market is the rising incidence of chronic diseases including cancer and autoimmune disorders. The increasing availability of biologics and pharmaceutical items used to treat these disorders has increased the demand for virus filtration technology and is driving revenue growth of the market. The demand for cutting-edge virus filtering technology in the biopharmaceutical industry is being driven by the need for safe and effective medicines.
Another factor raising demand for viral filtering technology in the biopharmaceutical sector is the expanding tendency of outsourcing biologic manufacturing to Contract Research Organizations (CROs) and Contract Manufacturing Organizations (CMOs). With a lack of manufacturing capacity brought on by rising demand for biologics and therapeutic medicines, manufacturing has been outsourced to CROs and CMOs. During the forecast period, this tendency is expected to drive revenue growth of the market.
With the presence of numerous biopharmaceutical firms and the deployment of cutting-edge virus filtration technologies, the North American region dominates the virus filtration market. With the rising demand for biologics and therapeutic goods, the expanding outsourcing of biologic manufacturing to CROs and CMOs, and the rising incidence of viral infections in the region, the Asia Pacific region is expected to experience considerable growth during the forecast period.
In the upcoming years, several restraining factors are expected to hamper the global virus filtration market revenue growth. The high cost of virus filtration goods and services is one of the major factors this sector faces. The specialized process of virus filtration necessitates expensive machinery and technology, raising the cost of production. Small and medium-sized businesses may find it difficult to afford virus filtration services as a result, which can result in little market competition.
The absence of standardized rules and regulations for viral filtration is a key barrier to revenue growth of the global virus filtration market. The regulatory environment for viral filtering goods and services differs across continents and countries, which causes manufacturers and customers to be perplexed and apprehensive. The expansion of the market can be hampered by uneven product quality and safety caused by unclear guidelines.
The limited uptake of viral filtration technology in developing countries can also be a major obstacle to market revenue growth. The adoption of virus filtration goods and services in emerging nations can be hampered by the high cost of virus filtration technology and the lack of end-user understanding. This can limit the market ability to expand in these areas, which are expected to experience rapid expansion in the pharmaceutical and biotechnology sectors in the years to come.
Product Types Outlook:
Kits and reagents, filtration systems, and services make up the three main segments that make up the viral filtration market. The global viral filtration market's greatest revenue share in 2021 belonged to filtration systems. Many reasons, including the rising frequency of viral infections, the rising demand for biologics and biosimilars, and the rising expenditure in R&D activities, are propelling the market growth of this category. Many different biopharmaceutical products, including vaccinations, monoclonal antibodies, and recombinant proteins, are filtered to remove viruses. These technologies are increasingly being used in the biopharmaceutical sector thanks to benefits including high specificity, high throughput, and high repeatability. Moreover, it is anticipated that during the projected period, the development of novel filtering systems with improved virus removal efficiency will fuel the segment's expansion.
Throughout the projected period, the kits and reagents segment is anticipated to post the quickest revenue CAGR. This market's expansion is attributed to both the rising popularity of self-testing and the rising need for diagnostic kits for the identification of viral infections. For the quick identification of viral illnesses like HIV, hepatitis, and influenza, diagnostic kits are employed. These kits are increasingly being used in hospitals and clinics due to their benefits such simplicity of use, speedy results, and affordability. Also, during the projection period, the prevalence of viral illnesses is predicted to increase, as is public awareness of early disease identification.
Throughout the projection period, the services category is anticipated to expand significantly as well. The rising need for contract research and manufacturing services in the biopharmaceutical industry is what is fueling the market expansion of this sector. Many contract research organisations (CROs) and contract manufacturing organisations (CMOs) provide biopharmaceutical businesses with services like virus elimination validation, process development, and viral filtration testing. During the projected period, this segment's expansion is anticipated to be fueled by the growing trend of outsourcing research and development activities.
Pharmaceutical and biotechnology firms, contract research organisations (CROs), and academic research facilities make up the different market segments for virus filtering. The greatest revenue share in the global virus filtering market in 2021 belonged to pharmaceutical and biotechnology firms. Many reasons, including the rising demand for biologics and biosimilars, the rising expenditure in research and development activities, and the rising prevalence of viral infections, are propelling the market growth of this category. For the creation of numerous biopharmaceutical goods, including vaccinations, monoclonal antibodies, and recombinant proteins, these businesses need viral filtering. Pharmaceutical and biotechnology businesses are using viral filtering more frequently as a result of the rising demand for biopharmaceutical goods and the necessity to ensure their safety and efficacy.
Throughout the projected period, the contract research organisations (CROs) segment is anticipated to post the quickest revenue CAGR. This market's expansion is linked to pharmaceutical and biotechnology businesses' growing outsourcing of their R&D operations. CROs provide biopharmaceutical firms with a range of services including virus filtration testing, process development, and virus elimination validation. Throughout the projection period, the benefits of outsourcing research and development activities, including cost-effectiveness and a shorter time to market, are anticipated to propel the segment's expansion.
Throughout the forecast period, the academic research institutes category is anticipated to expand significantly as well. The increased investment made by academic institutions in research and development activities is what is fueling the market expansion of this sector. For the purification of viruses and viral proteins, academic research centres that study diverse viral illnesses and disorders need to utilise virus filtration. This category is anticipated to develop over the forecast period due to rising viral illness awareness and the necessity of early disease identification.
Because to the increased prevalence of chronic diseases and the rising need for biologics, North America is anticipated to dominate the Virus Filtration Market during the forecast period. Major biopharmaceutical corporations and research institutions are present in this area, which is anticipated to boost market expansion.
The Virus Filtration Market is anticipated to expand significantly in the Asia Pacific region over the course of the projected year. The main drivers of market expansion in this region are the rising demand for biopharmaceuticals and the rising investment in research & development activities. Additionally, it is anticipated that the availability of cheap labour and raw materials in developing nations like China and India will further accelerate market expansion.
Throughout the projection period, a moderate rate of growth in the European market is anticipated. The main drivers of market expansion in this region are the rising demand for biopharmaceutical goods and increased expenditure in research & development activities. Market expansion in this region is anticipated to be fueled by the existence of significant biopharmaceutical businesses and research institutions in nations like Germany and the UK.
Major Companies and Competitive Landscape
Some major players in the global virus filtration market are:
launches of new products:
Segments Covered in Report:
By Product Type